CME/CE: Endovascular Clot Removal Wins Again
Publication Date:
Fri, 05/01/2015
By: Alere Staff
SPONSORED BY
American Heart Association
MedPage Today
ACTIVE DATE
April 17, 2015 – April 17, 2017
CREDIT
Physicians: 0.25 AMA PRA Category 1 Credit(s) ™
DESCRIPTION
Endovascular clot removal within 8 hours of onset improved outcomes for certain acute ischemic strokes in the REVASCAT trial, although not quite as much as with earlier thrombectomy in several recent trials.
LINK
For Healthcare Professionals
- Getting Started with Home INR Monitoring
- Continuing Education
- Patient Education
-
Recent News
- Alere Initiates Voluntary Withdrawal for the Alere INRatio® PT/INR Monitor System
- Alere Initiates Voluntary Urgent Medical Device Correction for the Alere INRatio® PT/INR Monitor System
- Alere Initiates Voluntary Urgent Product Recall of the Alere INRatio®2 PT/INR Professional Test Strip
- Roche Initiates Voluntary Urgent Product Recall of CoaguChek® XS, CoaguChek XS Plus, and CoaguChek XS Pro Meters
- Effect of PST on Warfarin Management and Major Clinical Outcomes
- New Agents Get Second Opinion for First Line Use
- Tools for Your Anticoagulation Patients
- Alere Webinars